Spots Global Cancer Trial Database for Study of Early-stage Lung Adenocarcinoma for Early Detection and Effective Treatment Strategy
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Study of Early-stage Lung Adenocarcinoma for Early Detection and Effective Treatment Strategy
Official Title: Prospective Study of Early-stage Lung Adenocarcinoma for Early Detection and Effective Treatment Strategy
Study ID: NCT01482585
Conditions
Interventions
Study Description
Brief Summary: to determine the values of imaging and genetic biomarkers for prediction of tumor aggressiveness and prognosis in patient with early stage lung adenocarcinoma to Identify unique copy number alteration in patient with early stage lung adenocarcinoma to evaluate the long-term change of ground-glass nodule combined with lung adenocarcinoma to suggest a guideline for planning an appropriate follow-up examination and management
Detailed Description:
Eligibility
Minimum Age: 20 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Samsung Medical Center, Seoul, , Korea, Republic of
Contact Details
Name: Young Mog Shim, Dr.
Affiliation: Samsung Medical Center
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
